Search hospitals
>
Oregon
>
Portland
OHSU Knight Cancer Institute
Claim this profile
Portland, Oregon 97239
Global Leader in Breast Cancer
Global Leader in Leukemia
Conducts research for Prostate Cancer
Conducts research for Cancer
Conducts research for Lymphoma
427 reported clinical trials
52 medical researchers
Summary
OHSU Knight Cancer Institute is a medical facility located in Portland, Oregon. This center is recognized for care of Breast Cancer, Leukemia, Prostate Cancer, Cancer, Lymphoma and other specialties. OHSU Knight Cancer Institute is involved with conducting 427 clinical trials across 430 conditions. There are 52 research doctors associated with this hospital, such as Lara Davis, MD, Zahi Mitri, Shivaani Kummar, MD, and Jeremy P. Cetnar.
Area of expertise
Breast Cancer
OHSU Knight Cancer Institute has run 56 trials for Breast Cancer. Some of their research focus areas include:
Leukemia
OHSU Knight Cancer Institute has run 55 trials for Leukemia. Some of their research focus areas include:
Top PIs
Lara Davis, MD
OHSU Knight Cancer Institute
6 years of reported clinical research
Zahi Mitri
OHSU Knight Cancer Institute
2 years of reported clinical research
Shivaani Kummar, MD
Oregon Health and Science University
1 year of reported clinical research
Jeremy P. Cetnar
Oregon Health and Science University
6 years of reported clinical research
Clinical Trials running at OHSU Knight Cancer Institute
Pancreatic Cancer
Acute Myeloid Leukemia
Cancer
Rectal Cancer
Prostate Cancer
Leukemia
Breast Cancer
Chronic Lymphocytic Leukemia
Brain Tumor
Cutaneous Melanoma
Indocyanine Green
for Pancreatic Cancer
This study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.
Recruiting
1 award
N/A
8 criteria
Axatilimab + Retifanlimab + Paclitaxel
for Cancer
This phase I/II trial tests the safety, side effects, and effectiveness of axatilimab in combination with retifanlimab and paclitaxel for the treatment of patients with a solid tumor that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). Axatilimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as retifanlimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Giving axatilimab in combination with retifanlimab and paclitaxel may be safe, tolerable and/or effective in treating patients with advanced or metastatic solid tumors.
Recruiting
1 award
Phase 1 & 2
Targeted Drug Therapy
for Pancreatic Cancer
This trial is testing four experimental drugs to see if they can help treat pancreatic cancer. The drugs work by blocking important processes that cancer cells need to grow and survive. The trial focuses on patients with pancreatic cancer who do not respond well to standard treatments. Gemcitabine was the first agent investigated for its potential to improve symptoms and overall well-being in pancreatic cancer patients.
Recruiting
1 award
Phase < 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at OHSU Knight Cancer Institute?
OHSU Knight Cancer Institute is a medical facility located in Portland, Oregon. This center is recognized for care of Breast Cancer, Leukemia, Prostate Cancer, Cancer, Lymphoma and other specialties. OHSU Knight Cancer Institute is involved with conducting 427 clinical trials across 430 conditions. There are 52 research doctors associated with this hospital, such as Lara Davis, MD, Zahi Mitri, Shivaani Kummar, MD, and Jeremy P. Cetnar.
Where is OHSU Knight Cancer Institute located?
The OHSU Knight Cancer Institute is situated on the South Waterfront campus in Portland, OR, located at 3181 S W Jackson Park Rd, Portland, OR 97239.
Who should I call to ask about financial aid or insurance network?
**OHSU Knight Cancer Institute Financial Assistance:** - For assistance with medical care costs at OHSU, Hillsboro Medical Center, and Adventist Health Portland, contact 503-494-8551 (Mon-Fri, 8 a.m. to 4:30 p.m. PT). - Eligibility includes those without health insurance, insufficient health insurance, or qualifying for state/federal assistance. **OHSU Knight Cancer Institute Insurance Department:** - For billing and insurance inquiries, call 866-617-6855. - This contact serves all OHSU Health hospitals and clinics for general billing and insurance questions, excluding some professional charges.
What insurance does OHSU Knight Cancer Institute accept?
The OHSU Knight Cancer Institute accepts a wide range of insurance plans, including but not limited to Aetna, CareOregon, Cigna, Health Net, Humana, Kaiser Permanente, Moda, Molina Healthcare, PacificSource, Providence Health Plan, Regence BlueCross BlueShield, and TriWest HealthCare Alliance. They also accept original Medicare, known as traditional Medicare. It's important to verify coverage with your insurance provider before receiving care.
What awards or recognition has OHSU Knight Cancer Institute received?
The OHSU Knight Cancer Institute, located in Portland, Oregon, is a National Cancer Institute-designated Comprehensive Cancer Center. This prestigious recognition places it among the nation's elite for laboratory and clinical research, community service, and multidisciplinary scientific research. It is also an active member of global cancer organizations and networks, positioning it at the forefront of cancer research and care.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.